Authors: Patricia Baird1, Eleanor Dyke2, Melanie Powell3, Alexandra Taylor4, Louise Hanna5, Ursula McGivern6, Jeffrey Summers7, Anupama Gore8, Audrey Cook9, Jennifer Forrest10, Alexandra Stewart11
1St Luke's Cancer Centre , Clinical Oncology , GUILDFORD, United Kingdom; 2St Luke’s Cancer Centre, Physics Department, GUILDFORD, United Kingdom; 3Barts Health NHS Trust, Clinical Oncology, London, United Kingdom; 4The Royal Marsden NHS Foundation Trust, Clinical Oncology, London , United Kingdom; 5Velindre University Hospital NHS Trust, Clinical Oncology, Cardiff, United Kingdom; 6Belfast City Hospital, Clinical Oncology, Belfast, United Kingdom; 7Maidstone and Tunbridge Wells NHS Trust, Clinical Oncology, Maidstone, United Kingdom; 8Leicester Royal Infirmary, Clinical Oncology, Leicester, United Kingdom; 9Gloucestershire Hospitals NHS Trus, Clinical Oncology, Gloucester, United Kingdom; 10Royal Devon University Hospital Trust, Clinical Oncology, Exeter, United Kingdom; 11Saint Luke's Cancer Centre , Clinical Oncology, GUILDFORD, United Kingdom